Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

NITD-349

🥰Excellent
Catalog No. T12231Cas No. 1473450-62-2

NITD-349 is an inhibitor of MmpL3. It shows highly potent anti-mycobacterial activity with MIC50 of 23 nM against virulent Mycobacterium tuberculosis H37Rv.

NITD-349

NITD-349

🥰Excellent
Purity: 99.89%
Catalog No. T12231Cas No. 1473450-62-2
NITD-349 is an inhibitor of MmpL3. It shows highly potent anti-mycobacterial activity with MIC50 of 23 nM against virulent Mycobacterium tuberculosis H37Rv.
Pack SizePriceAvailabilityQuantity
10 mg$44In Stock
25 mg$80In Stock
50 mg$133In Stock
100 mg$200In Stock
200 mg$283In Stock
1 mL x 10 mM (in DMSO)$30In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "NITD-349"

Select Batch
Purity:99.89%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
NITD-349 is an inhibitor of MmpL3. It shows highly potent anti-mycobacterial activity with MIC50 of 23 nM against virulent Mycobacterium tuberculosis H37Rv.
Targets&IC50
Mycobacterium tuberculosisH37Rv:23 nM (MIC50)
In vitro
NITD-304 and NITD-349, showed potent activity against both drug-sensitive and multidrug-resistant clinical isolates of Mtb. Promising pharmacokinetic profiles of both compounds after oral dosing in several species enabled further evaluation for efficacy and safety. NITD-304 and NITD-349 were efficacious in treating both acute and chronic Mtb infections in mouse efficacy models. Furthermore, dosing of NITD-304 and NITD-349 for 2 weeks in exploratory rat toxicology studies revealed a promising safety margin. Finally, neither compound inhibited the activity of major cytochrome P-450 enzymes or the hERG (human ether-a-go-go related gene) channel[1].
In vivo
In the acute murine efficacy model, treatment of mice with NITD-349 at doses of 12.5 and 50 mg/kg resulted in 0.9- and 3.4-log CFU reduction in lung tissue.In an established infection mouse model, after 2 weeks of treatment, the efficacy of NITD-349 is comparable to the first-line TB drug rifampicin and is better than ethambutol.Four weeks of treatment at 100 mg/kg with NITD-349 results in 2.38-log CFU reductions[1].
Chemical Properties
Molecular Weight306.35
FormulaC17H20F2N2O
Cas No.1473450-62-2
SmilesCC1(C)CCC(CC1)NC(=O)c1cc2c(F)cc(F)cc2[nH]1
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 310 mg/mL (1011.91 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.2642 mL16.3212 mL32.6424 mL163.2120 mL
5 mM0.6528 mL3.2642 mL6.5285 mL32.6424 mL
10 mM0.3264 mL1.6321 mL3.2642 mL16.3212 mL
20 mM0.1632 mL0.8161 mL1.6321 mL8.1606 mL
50 mM0.0653 mL0.3264 mL0.6528 mL3.2642 mL
100 mM0.0326 mL0.1632 mL0.3264 mL1.6321 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy NITD-349 | purchase NITD-349 | NITD-349 cost | order NITD-349 | NITD-349 chemical structure | NITD-349 in vivo | NITD-349 in vitro | NITD-349 formula | NITD-349 molecular weight